Deep-pocketed investors have adopted a bearish approach towards Cerevel Therapeutics Hldg CERE, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CERE usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Cerevel Therapeutics Hldg. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 11% leaning bullish and 44% bearish. Among these notable options, 3 are puts, totaling $1,610,000, and 6 are calls, amounting to $2,533,925.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $35.0 and $42.5 for Cerevel Therapeutics Hldg, spanning the last three months.
Insights into Volume & Open Interest
In today's trading context, the average open interest for options of Cerevel Therapeutics Hldg stands at 2521.71, with a total volume reaching 13,585.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Cerevel Therapeutics Hldg, situated within the strike price corridor from $35.0 to $42.5, throughout the last 30 days.
Cerevel Therapeutics Hldg 30-Day Option Volume & Interest Snapshot
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CERE | PUT | TRADE | BEARISH | 08/16/24 | $2.75 | $0.35 | $2.35 | $40.00 | $940.0K | 1.7K | 4.0K |
| CERE | CALL | TRADE | NEUTRAL | 10/18/24 | $3.7 | $3.0 | $3.3 | $40.00 | $660.0K | 92 | 2.1K |
| CERE | CALL | TRADE | BEARISH | 08/16/24 | $3.2 | $2.5 | $2.6 | $40.00 | $650.0K | 575 | 19 |
| CERE | CALL | TRADE | NEUTRAL | 10/18/24 | $3.5 | $3.0 | $3.25 | $40.00 | $650.0K | 92 | 105 |
| CERE | PUT | TRADE | BEARISH | 08/16/24 | $1.65 | $0.1 | $1.3 | $35.00 | $520.0K | 2.0K | 4.0K |
About Cerevel Therapeutics Hldg
Cerevel Therapeutics Holdings Inc is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. It has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinson's disease and substance use disorder. Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions.
Cerevel Therapeutics Hldg's Current Market Status
- Currently trading with a volume of 5,459,634, the CERE's price is down by 0.0%, now at $41.42.
- RSI readings suggest the stock is currently may be approaching oversold.
- Anticipated earnings release is in 37 days.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Cerevel Therapeutics Hldg, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
